|
Earnings Preview: J&J to cite deals, drugs OK'dThe Associated PressDuring the third quarter, the maker of baby shampoo, biologic medicines and birth control pills saw several drugs win new approvals, including extended-release Nucynta, a narcotic pill for moderate-to-severe chronic pain. One product was rejected. ...and more » |